Efe, C. Et Al. 2017. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.12 , 1950-1957.

Efe, C., Hagstrom, H., Ytting, H., Bhanji, R. A., Muller, N. F., Wang, Q., ... PÜRNAK, T.(2017). Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.12, 1950-1957.

Efe, Cumali Et Al. "Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis," CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.12, 1950-1957, 2017

Efe, Cumali Et Al. "Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis." CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.12, pp.1950-1957, 2017

Efe, C. Et Al. (2017) . "Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis." CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , vol.15, no.12, pp.1950-1957.

@article{article, author={Cumali Efe Et Al. }, title={Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis}, journal={CLINICAL GASTROENTEROLOGY AND HEPATOLOGY}, year=2017, pages={1950-1957} }